Inspire Medical Systems, Inc. Announces First Quarter 2024 Financial Results and Updates 2024 Outlook Inspire Reports Year-over-YearRevenue Growth of 28% in the First Quarter and Expects Profitability for the Full Year 2024 MINNEAPOLIS, May 07, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter ended March 31, 2024. Recent Business Highl...
MARTEN TRANSPORT DECLARES QUARTERLY DIVIDEND MONDOVI, Wis., May 07, 2024 (GLOBE NEWSWIRE) -- Marten Transport, Ltd. (Nasdaq/GS:MRTN) announced today that its Board of Directors has declared a regular quarterly cash dividend of $0.06 per share of common stock. The dividend will be payable on June 28, 2024 to stockholders of record at the close of business on June 14, 2024. This is Marten’s 56th consecutive quarterly cash dividend. With the payment of this dividend, Marten will have paid a total of $241.9 million in cash dividends, including special dividends totaling $134.9 million in 202...
LegalZoom Reports First Quarter 2024 Financial Results Revenue of $174.2 million for the quarter, an increase of 5% year-over-yearSubscription revenue of $107.9 million for the quarter, an increase of 10% year-over-year$228.1 million of cash and cash equivalents and no debt outstanding as of March 31, 2024 MOUNTAIN VIEW, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- LegalZoom.com, Inc. (Nasdaq: LZ), the No. 1 choice in online small business formations, today announced results for its first quarter ended March 31, 2024. “I am excited by the momentum we are seeing across our ecosystem. We bega...
Mercury Systems Reports Third Quarter Fiscal 2024 Results Q3 FY24 Bookings of $219.9 million; book-to-bill ratio of 1.06Q3 FY24 Revenue of $208.3 million; GAAP net loss and adjusted EBITDA ($44.6) million and ($2.4) million, respectivelyRecord backlog of $1.3 billion; up 17% year-over-year ANDOVER, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Mercury Systems, Inc. (NASDAQ: MRCY, ), reported operating results for the third quarter of fiscal year 2024, ended March 29, 2024. “In the third quarter of fiscal year 2024, we made solid progress in each of our four priority focus areas which incl...
LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announces another milestone achieved on its U.S. Highway 93 go-to-market program – a strategic agreement with IQ Laser Vision, a leader in providing clear vision to clients with locations across California and Texas, and a top EVO ICL practice in North America. This press release features multimedia. View the full release here: Tom Frinzi, Chair of the Board, Presi...
TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024 SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with other life science companies, announced today that it will report its first quarter 2024 financial and operating results after the close of U.S. financial markets on Tuesday, May 14, 2024. In addition, managem...
Grocery Outlet Holding Corp. Announces First Quarter Fiscal 2024 Financial Results Q1 fiscal 2024 net sales increased 7.4%Q1 fiscal 2024 comparable store sales grew 3.9%, driven by a 7.0% increase in transactionsCompany updates key guidance for fiscal 2024 EMERYVILLE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Grocery Outlet Holding Corp. (NASDAQ: GO) ("Grocery Outlet" or the "Company") today announced financial results for the first quarter of fiscal 2024 ended March 30, 2024. Highlights for First Quarter Fiscal 2024 as compared to First Quarter Fiscal 2023: Net sales increased by 7.4% ...
Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights SOUTH SAN FRANCISCO, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for the treatment of neurodegenerative diseases and lysosomal storage diseases, today reported financial results for the first quarter ended March 31, 2024, and provided business highlights. "It has been an impactful first quarter, and we are excited about multiple opportu...
ARKO Corp. Reports First Quarter 2024 Results RICHMOND, Va., May 07, 2024 (GLOBE NEWSWIRE) -- ARKO Corp. (Nasdaq: ARKO) (“ARKO” or the “Company”), a Fortune 500 company and one of the largest convenience store operators in the United States, today announced financial results for the first quarter ended March 31, 2024. First Quarter 2024 Key Highlights (vs. Year-Ago Quarter)1,2 Net loss for the quarter was $0.6 million compared to $2.5 million.Adjusted EBITDA for the quarter was $36.6 million compared to $47.5 million, with the variance driven by lower fuel contribution, regulatory state...
Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference HAMILTON, Bermuda, May 07, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the Bank of America Securities 2024 Healthcare Conference on Tuesday, May 14, 2024 at 10:40 a.m. Pacific Time (1:40 p.m. Eastern Time). A live webcast of Kiniksa’s presentation will be accessible through the Investors & Media section of the company’s website at . A replay of the event will also be available on Kiniksa’s website within approximately 48 hours af...
United Fire Group, Inc. Reports First Quarter 2024 Results First Quarter Net Income of $0.52 per Diluted Share and Adjusted Operating Income of $0.56 per Diluted Share First quarter 2024 highlights: Net income of $13.5 million increased compared to the first quarter of 2023, driven by underwriting income and higher investment income.Net premiums written(1) of $321.3 million increased 17.6% compared to the first quarter of 2023.GAAP combined ratio of 98.9%, including a loss ratio of 64.0% and underwriting expense ratio of 34.9%, improved 4.5 points compared to the first quarter of ...
Micron Technology Announces Upcoming Investor Events BOISE, Idaho, May 07, 2024 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU) announced today that company executives will participate in fireside chats at the following investor events: J.P. Morgan’s 52nd Annual Global Technology, Media and Communications Conference in Boston on Tuesday, May 21 at 6:10 a.m. Mountain time.Goldman Sachs’ Global Semiconductor Conference in New York on Thursday, May 30 at 6:20 a.m. Mountain time. Live webcasts and subsequent replays of presentations can be accessed from Micron’s Investor Relati...
Capital Southwest expands Executive Team with Key Promotions DALLAS, May 07, 2024 (GLOBE NEWSWIRE) -- Capital Southwest Corporation (“Capital Southwest”) (Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, announced today that its Board of Directors has approved the promotion of Josh Weinstein to Senior Managing Director and Chief Investment Officer and Chris Rehberger to Executive Vice President and Treasurer, effective immediately. Bowen Diehl, Capital Sou...
Conifer Holdings Schedules First Quarter 2024 Earnings Conference Call/Webcast for May 15, 2024 TROY, Mich., May 07, 2024 (GLOBE NEWSWIRE) -- Conifer Holdings, Inc. (Nasdaq: CNFR) announced today that it will host a conference call/webcast on Wednesday, May 15, 2024 at 8:30am Eastern Time to discuss financial results for the first quarter ended March 31, 2024. The Company plans to release its first quarter financial results after the market closes on Tuesday, May 14, 2024. Investors, analysts, employees and the public are invited to listen to the conference call via: Webcast:or on the Ev...
Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference VANCOUVER, British Columbia, May 07, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced that the company will present at the 2024 RBC Capital Markets Global Healthcare Conference taking place May 14-15, 2024 in New York, NY. Fireside Chat Presentation Details: Date:Tuesday, May 14, 2024Time:3:35 pm Eastern TimeWebcast:Presenters:Ian Mortimer, President and Chief Executive OfficerSherry Aulin, Chief Financial Of...
SEATTLE--(BUSINESS WIRE)-- Redfin Corporation (NASDAQ: RDFN) today announced results for its first quarter ended March 31, 2024. First Quarter 2024 First quarter revenue was $225.5 million, an increase of 5% compared to the first quarter of 2023. Gross profit was $70.8 million, an increase of 22% year-over-year. Real estate services gross profit was $20.3 million, an increase of 28% year-over-year, and real estate services gross margin was 15%, compared to 12% in the first quarter of 2023. Net loss was $66.8 million, compared to a net loss of $60.8 million in the first quarter of 2023. N...
Inception Growth Acquisition Limited Announces Listing Transfer to the Nasdaq Capital Market New York, NY, May 07, 2024 (GLOBE NEWSWIRE) -- Inception Growth Acquisition Limited (Nasdaq: IGTA) (the “Company”) announced today that it has received approval from the Nasdaq Stock Market LLC (“Nasdaq”) to list its securities on the Nasdaq Capital Market. The securities will be transferred from the Nasdaq Global Market to the Nasdaq Capital Market at the opening of business on May 8, 2024. The Company’s common stock, units, warrants and rights will continue to trade under the symbols “IGTA”, “I...
Pacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Repurchase program -- Conference call today at 4:30 p.m. ET -- TAMPA, Fla., May 07, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported financial results for the first quarter of 2024. First Quarter 2024 Financial Highlights Total revenues of $167.1 millionNet product sales of $132.4 million for EXPAREL, $25.8 million for ZILRETTA, and $5.0 million for iovera°N...
Acumen Pharmaceuticals to Report First Quarter Results on May 14, 2024 CHARLOTTESVILLE, Va., May 07, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s disease, today announced that the Company will report first quarter 2024 financial results on Tuesday, May 14, 2024. The Company will host a conference call and live audio webcast at 8:00 a.m. ET to provide a business and financial update. To participate in the live...
Cytokinetics to Hold Annual Meeting of Stockholders SOUTH SAN FRANCISCO, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that its Annual Meeting of Stockholders will be held on Wednesday, May 15, 2024 at 10:00 AM Pacific Time at the Company’s headquarters, 350 Oyster Point Blvd., South San Francisco, CA. Immediately after the conclusion of the Annual Meeting of Stockholders, Robert I. Blum, President and Chief Executive Officer, is scheduled to present an overview of Cytokinetics’ performance. Stockholders of record at the close of busin...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.